National Advisory Committee on Immunization (NACI) is increasing its age recommendation for Johnson & Johnson’s COVID-19 vaccine to adults 30-years and older.“At this time and based on current evidence, NACI recommends the Janssen COVID-19 vaccine may be offered to individuals 30 years of age and older without contraindications, if the individual does not wish to wait for an mRNA vaccine and if the benefits outweigh the risk for the individual,” NACI said in a statement released online.